Acorda Therapeutics Inc Book/Share
What is the Book/Share of Acorda Therapeutics Inc?
The Book/Share of Acorda Therapeutics Inc is -8.21
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with book/share similar to Acorda Therapeutics Inc
- Opto Circuits (India) has Book/Share of -8.45
- California Resources Corp has Book/Share of -8.41
- MBIA has Book/Share of -8.37
- Dynavision has Book/Share of -8.27
- Vivint Smart Home Inc has Book/Share of -8.24
- Rusoro Mining has Book/Share of -8.22
- Acorda Therapeutics Inc has Book/Share of -8.21
- Town Sports International has Book/Share of -8.11
- MDC Partners has Book/Share of -8.06
- Ansal Properties & Infrastructure has Book/Share of -8.05
- Lanesborough Real Estate Investment Trust has Book/Share of -8.04
- Mechel PJSC has Book/Share of -7.79
- Setco Automotive has Book/Share of -7.77